SVA [SINOVAC BIOTECH] 6-K: SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY

[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent SECOND AMENDMENT TO RIGHTS AGREEMENT Effective as of June 26, 2017 Amendment Rights Agreement Company Rights Agent Amalgamation Agreement Parent provided however This Second Amendment (this “ WHEREAS, the Company and the Rights ]

By | 2017-07-01T03:04:41+00:00 June 30th, 2017|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: This Form 6-K consists of: 1. 2. An

[This Form 6-K consists of: 1. 2. An announcement regarding election of chairman of the board of supervisors and change in supervisors; 3. 4. A list of directors and their roles and function; Document 1 CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s]

By | 2017-07-01T03:05:59+00:00 June 30th, 2017|Categories: Chinese Stocks, SNP, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Announces Fourth Quarter and Year

[China Jo-Jo Drugstores Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2017 -- FY 2017 Retail Pharmacy Sales increased by 1.1%; Gross Margin Increased From 19.7% to 20.4%; 9 New Pharmacies Added in 2017 (net) HANGZHOU, China, June 29, 2017 /PRNewswire/ -- China Jo-Jo Drugstor]

BIDU [Baidu] 424B2: Prospectus Supplement (To Prospectus dated June 26, 2017)

[Prospectus Supplement (To Prospectus dated June 26, 2017) US$1,500,000,000 Baidu, Inc. US$900,000,000 2.875% Notes due 2022 US$600,000,000 3.625% Notes due 2027 We are offering US$900,000,000 of our 2.875% notes due 2022 (the “2022 Notes”) and US$600,000,000 of our 3.625% notes due 2027 (the “2027 N]

BIDU [Baidu] 6-K: Baidu Announces Pricing of US$1.5 Billion Notes Offering

[Baidu Announces Pricing of US$1.5 Billion Notes Offering The Company expects to receive net proceeds from the offering of approximately US$1.49 billion, after deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the net proceeds from the offeri]

CJJD [CHINA JO-JO DRUGSTORES] 10-K: TO ANNUAL REPORT ON FORM 10-K FOR YEAR

[TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED MARCH 31, 2017 Page PART I. Item 1. Business. 1 Item 1A. Risk Factors. 15 Item 1B. Unresolved Staff Comments. 32 Item 2. Properties. 33 Item 3.] [CHINA JO-JO DRUGSTORES, INC. March 29, 2017 Via Email Dear Ms. Wang: Our company compensates our non-employee]

Skip to toolbar